Your browser doesn't support javascript.
loading
Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification.
Ursenbach, Axel; Ruch, Yvon; Hoellinger, Baptiste; Fuchs, Anne; Caspar, Stéphanie; Jegou, Frédérick; Rey, David; Fafi-Kremer, Samira; Mesplède, Thibault; Gantner, Pierre.
  • Ursenbach A; Le Trait d'Union, HIV-Infection Care Center, Strasbourg University Hospital, Strasbourg, France.
  • Ruch Y; Infectious Diseases Department, Strasbourg University Hospital, Strasbourg, France.
  • Hoellinger B; Infectious Diseases Department, Strasbourg University Hospital, Strasbourg, France.
  • Fuchs A; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Caspar S; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Jegou F; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Rey D; Le Trait d'Union, HIV-Infection Care Center, Strasbourg University Hospital, Strasbourg, France.
  • Fafi-Kremer S; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Mesplède T; INSERM UMR_S1109, Strasbourg University, Strasbourg, France.
  • Gantner P; Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands.
Clin Infect Dis ; 79(1): 198-201, 2024 Jul 19.
Article en En | MEDLINE | ID: mdl-38193816
ABSTRACT
Dolutegravir/lamivudine (DTG/3TC) has a high genetic barrier against the development of human immunodeficiency virus drug resistance. We report 2 cases of R263K + M184V mutations during DTG/3TC failure followed by viral suppression after adherence intervention without treatment change that we attribute to residual drug activity, reduced viral fitness, and robust immune competence.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxazinas / Piperazinas / Piridonas / Infecciones por VIH / Lamivudine / Fármacos Anti-VIH / Farmacorresistencia Viral / Compuestos Heterocíclicos con 3 Anillos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxazinas / Piperazinas / Piridonas / Infecciones por VIH / Lamivudine / Fármacos Anti-VIH / Farmacorresistencia Viral / Compuestos Heterocíclicos con 3 Anillos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article